Skip to main content
Year archive

BIOTRON LIMITED — 2018 filings

All 61 regulatory filings released by BIOTRON LIMITED (BIT) in 2018, sourced directly from the official regulator.

61 Filings
2018 Period
2018 filings (61)
Filing Released Lang
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-12-13 English
Letter to Shareholders 2 pages 213.5KB
Investor Presentation
2018-12-11 English
Exercise of Options Raises $4.7 Million 13 pages 144.8KB
Capital/Financing Update
2018-12-04 English
Change of Director's Interest Notice 3 pages 641.9KB
Director's Dealing
2018-12-02 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-11-29 English
PRESENTATION OF BIT225-009 HIV-1 PHASE 2 DATA 3 pages 3.0MB
Investor Presentation
2018-11-27 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-11-22 English
Change of Director's Interest Notice 3 pages 643.4KB
Director's Dealing
2018-11-22 English
Change of Principal Place of Business 1 page 227.9K
Regulatory Filings
2018-11-21 English
AGM Presentation 22 pages 1.1MB
AGM Information
2018-11-19 English
Results of Meeting 2 pages 323.0KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-19 English
Re-Appointment of a Director 1 page 30.2KB
Board/Management Information
2018-11-19 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-11-15 English
Presentation of BIT225-009 HIV-1 Phase 2 Data 2 pages 31.2KB
Regulatory Filings
2018-11-12 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-11-08 English
Change of Director's Interest Notice 3 pages 657.0KB
Director's Dealing
2018-11-08 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-11-01 English
Change of Director's Interest Notice 5 pages 671.4KB
Director's Dealing
2018-11-01 English
Response to ASX aware letter 12 pages 631.3KB
Regulatory Filings
2018-10-29 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-10-28 English
Option Expiry Notice 5 pages 553.1KB
Capital/Financing Update
2018-10-28 English
Presentation to Investors 17 pages 5.9MB
Investor Presentation
2018-10-24 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-10-24 English
Change of Director's Interest Notice 8 pages 688.2KB
Director's Dealing
2018-10-24 English
Appendix 4C - quarterly 5 pages 93.1KB
Interim / Quarterly Report Q1 2019
2018-10-23 English
Appendix 3B 13 pages 1.0MB
Share Issue/Capital Change
2018-10-23 English
Appointment of a Director and Appendix 3X 4 pages 33.0KB
Board/Management Information
2018-10-22 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-10-22 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-10-21 English
Annual Report and Notice of AGM 60 pages 7.8MB
Annual Report FY 2018
2018-10-17 English
Appendix 3B 13 pages 139.6KB
Capital/Financing Update
2018-10-17 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update
2018-10-17 English
Biotron Secures $4.7 Million Underwriting Agreement 2 pages 36.9KB
Capital/Financing Update
2018-10-16 English
$1.07 million R&D Tax Incentive Received 1 page 43.
Capital/Financing Update
2018-10-14 English
Appendix 3B 13 pages 427.9KB
Capital/Financing Update
2018-10-10 English
Letter to Shareholders 2 pages 164.0KB
Regulatory Filings
2018-10-08 English
Significant Immunological Outcomes in BIT225 HIV-1 Trial 3 pages 415.4KB
Regulatory Filings
2018-09-27 English
Full Year Statutory Accounts 52 pages 2.1MB
Annual Report FY 2018
2018-08-28 English
Appendix 4G and Corporate Governance Statement 20 pages 736.6KB
Governance Information
2018-08-28 English
Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial 2 pages 391.5KB
Regulatory Filings
2018-08-06 English
Appendix 4C - quarterly 5 pages 701.4KB
Interim / Quarterly Report Q4 2018
2018-07-10 English
Appendix 3B 13 pages 914.0KB
Capital/Financing Update
2018-07-09 English
New Issue Announcement 14 pages 1.0MB
Capital/Financing Update
2018-06-13 English
Change of Director's Interest Notice 9 pages 700.1KB
Director's Dealing
2018-06-13 English
New Issue Oversubscribed 1 page 295.4KB
Capital/Financing Update
2018-06-11 English
Appendix 3B 13 pages 835.8KB
Capital/Financing Update
2018-05-27 English
Appendix 3B 13 pages 835.8KB
Capital/Financing Update
2018-05-15 English
Letter to Eligible and Ineligible Shareholders 5 pages 547.0KB
Capital/Financing Update
2018-05-10 English
Renounceable Rights Issue 23 pages 5.8MB
Capital/Financing Update
2018-05-09 English
Appendix 3B 14 pages 920.6KB
Capital/Financing Update
2018-05-09 English
Letter to Option Holders 3 pages 559.3KB
Capital/Financing Update
2018-05-09 English
Prospectus 42 pages 1.0MB
Capital/Financing Update
2018-05-09 English
Response to ASX Price Query 5 pages 649.3KB
Regulatory Filings
2018-05-09 English
Response to ASX Appendix 4C Query 4 pages 1.0MB
Regulatory Filings
2018-05-09 English
Trading Halt 1 page 70.4KB
Regulatory Filings
2018-05-07 English
Trading Halt Request 1 page 329.5KB
Capital/Financing Update
2018-05-07 English
Appendix 4C - quarterly 5 pages 700.7KB
Interim / Quarterly Report Q3 2018
2018-04-23 English
Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial 2 pages 465.8KB
Regulatory Filings
2018-04-05 English
Half Yearly Report and Accounts 20 pages 323.9KB
Interim / Quarterly Report H1 2018
2018-02-22 English
Appendix 4C - quarterly 5 pages 90.9KB
Interim / Quarterly Report Q2 2018
2018-01-15 English
Biotron Presents to Biotech Showcase 2018 23 pages 1.6MB
Investor Presentation
2018-01-09 English